These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26992487)

  • 1. Lumbosacral Plexus Involvement as the First Site of Metastatic Recurrence in a Patient With CTNNB1-Mutant Prostate Cancer.
    Markowski MC; Wobker SE; Strowd RE; Antonarakis ES
    Clin Genitourin Cancer; 2016 Aug; 14(4):e417-22. PubMed ID: 26992487
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenocarcinoma of the prostate involving the lumbosacral plexus: MRI evidence to support direct perineural spread.
    Hébert-Blouin MN; Amrami KK; Myers RP; Hanna AS; Spinner RJ
    Acta Neurochir (Wien); 2010 Sep; 152(9):1567-76. PubMed ID: 20473531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent rectal cancer causing lumbosacral plexopathy with perineural spread to the spinal nerves and the sciatic nerve: an anatomic explanation.
    Capek S; Sullivan PS; Howe BM; Smyrk TC; Amrami KK; Spinner RJ; Dozois EJ
    Clin Anat; 2015 Jan; 28(1):136-43. PubMed ID: 25090969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical model of perineural tumor spread: a pilot study.
    Jacobs JJ; Capek S; Spinner RJ; Swanson KR
    Acta Neurochir (Wien); 2018 Mar; 160(3):655-661. PubMed ID: 29264779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer with perineural spread and dural extension causing bilateral lumbosacral plexopathy: case report.
    Capek S; Howe BM; Tracy JA; García JJ; Amrami KK; Spinner RJ
    J Neurosurg; 2015 Apr; 122(4):778-83. PubMed ID: 25658791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perineural tumor spread to the muscle: An alternative for muscle metastasis?
    Capek S; Amrami KK; Howe BM; Spinner RJ
    Clin Anat; 2015 Jul; 28(5):560-2. PubMed ID: 25511297
    [No Abstract]   [Full Text] [Related]  

  • 7. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
    Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
    Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent prostatic adenocarcinoma with perineural spread to the lumbosacral plexus and sciatic nerve: comparing high resolution MRI with torso and endorectal coils and F-18 FDG and C-11 choline PET/CT.
    Babu MA; Spinner RJ; Dyck PJ; Amrami KK; Nathan MA; Kawashima A; Howe BM
    Abdom Imaging; 2013 Oct; 38(5):1155-60. PubMed ID: 23494714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.
    Horvath LG; Henshall SM; Lee CS; Kench JG; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
    Int J Cancer; 2005 Jan; 113(3):415-22. PubMed ID: 15455387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cilia are lost in preinvasive and invasive prostate cancer.
    Hassounah NB; Nagle R; Saboda K; Roe DJ; Dalkin BL; McDermott KM
    PLoS One; 2013; 8(7):e68521. PubMed ID: 23844214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.
    Lee SH; Luong R; Johnson DT; Cunha GR; Rivina L; Gonzalgo ML; Sun Z
    Oncogene; 2016 Feb; 35(6):702-14. PubMed ID: 25893287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer.
    Caso JR; Tsivian M; Mouraviev V; Polascik TJ; Moul JW
    BJU Int; 2010 Dec; 106(11):1623-7. PubMed ID: 20553260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoplastic lumbosacral radiculoplexopathy in prostate cancer by direct perineural spread: an unusual entity.
    Ladha SS; Spinner RJ; Suarez GA; Amrami KK; Dyck PJ
    Muscle Nerve; 2006 Nov; 34(5):659-65. PubMed ID: 16810682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.
    Xia H; Ooi LL; Hui KM
    PLoS One; 2012; 7(9):e44206. PubMed ID: 22962603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perineural spread of pelvic malignancies to the lumbosacral plexus and beyond: clinical and imaging patterns.
    Capek S; Howe BM; Amrami KK; Spinner RJ
    Neurosurg Focus; 2015 Sep; 39(3):E14. PubMed ID: 26323816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the Canonical Wnt Pathway Activation on the Pathogenesis and Prognosis of Adamantinomatous Craniopharyngiomas.
    Jucá CEB; Colli LM; Martins CS; Campanini ML; Paixão B; Jucá RV; Saggioro FP; de Oliveira RS; Moreira AC; Machado HR; Neder L; Antonini SR; de Castro M
    Horm Metab Res; 2018 Jul; 50(7):575-581. PubMed ID: 29625497
    [No Abstract]   [Full Text] [Related]  

  • 17. Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin-mediated prostatic tumorigenesis.
    Aldahl J; Mi J; Pineda A; Kim WK; Olson A; Hooker E; He Y; Yu EJ; Le V; Lee DH; Geradts J; Sun Z
    J Biol Chem; 2020 Jan; 295(2):631-644. PubMed ID: 31819003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone.
    Saha B; Arase A; Imam SS; Tsao-Wei D; Naritoku WY; Groshen S; Jones LW; Imam SA
    Prostate; 2008 Jan; 68(1):78-84. PubMed ID: 18008331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is lymphovascular invasion a powerful predictor for biochemical recurrence in pT3 N0 prostate cancer? Results from the K-CaP database.
    Park YH; Kim Y; Yu H; Choi IY; Byun SS; Kwak C; Chung BH; Lee HM; Kim CS; Lee JY
    Sci Rep; 2016 May; 6():25419. PubMed ID: 27146602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt/β-catenin pathway.
    Li R; Quan Y; Xia W
    Exp Cell Res; 2018 Mar; 364(2):143-151. PubMed ID: 29421536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.